Phase 2 trial shows COVID-19 recombinant protein vaccine elicits promising immunogenicity responses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus 19 ...
Durability of immunity to SARS-CoV-2 reinfection
The most effective approaches that are currently a...
Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests
A promising study shows that a combination of two ...
Enveloped virus-like particle based vaccines potentially broaden immunity against SARS-CoV-2 variants
Coronavirus disease 2019 (COVID-19) pandemic led t...
Peripheral nerve injuries and severe COVID-19
The coronavirus disease 2019 (COVID-19) pandemic h...
Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection
A recent study published in the New England Journa...
A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2
Scientists believe that vaccinating the entire glo...
An oral COVID-19 vaccine induces mucosal and protective immunity
Vaccines have proven effective at helping control ...
Australia's response to COVID-19 pandemic
Coronavirus disease 2019 (COVID-19) was first iden...
German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage
The severe acute respiratory syndrome coronavirus ...